An Investigation into the Detection and Mitigation of Denial of Service (DoS) Attacks

Professor S V Raghavan is currently Scientific Secretary, Office of the Principal Scientific Advisor to Government of India. He is also a full Professor in the prestigious Indian Institute of technology Madras, Chennai. Professor Raghavan is the Chief Architect and the Chairman, Technical Advisory Committee to National Knowledge Network (NKN), a Government of India initiative to interconnect and integrate 1500 knowledge institutions in India and integrate NKN with global science through dedicated international linkages in a seamless manner. His current research interests are Technology, Health, and Education, where he has significant contributions in the recent years. Location technologies, Evolutionary addressing, Discovering Redundant multi-paths, IR Imaging for Breast Cancer, and pedagogy based adaptive and reusable learning modules are some of them. Professor Raghavan is the Project Director of the Indo-Australian Joint Project to understand Distributed Denial of Service Attacks onCritical Information Infrastructure. Professor Ed Dawson is a Professor Emeritus in the Information Security Institute. From 2005 until 2007, he was the Research Director of the Information Security Institute (ISI). Prior to the formation of the ISI, he was the Director of the Information Security Research Centre (ISRC). He has research interests in all aspects of cryptology especially related to the design and analysis of encryption algorithms and their application to e-commerce and secure communications. He has published over 250 research papers. Over the last five years, he has received over $7,000,000 in external funding. Professor Dawson was the Vice-President of the International Association of Cryptology Research (2008 – 2010) and the node leader of the Information Security component of the Australian Research Council networks, Research Networks for a Security Australia.

PREFACE.-1. Introduction.-2. Diversity oriented fluorescence library approach for stem cell probe development.-3. Isolation of mesenchymal stem cells from umbilical cord (method).-4. Mesenchymal stem cell isolation and expansion methodology.-5. Hair follicle stem cells.- 6. Rat embryonic cortical neural stem cells: role of hypoxia on cell proliferation and differentiation.-7. Human cord blood-derived hematopoietic stem and progenitor cells: from biology to medicine.-8. Proteomic characterization of mesenchymal stem cell-like populations derived from various tissue types.-9. The roles of nanog during early embryonic development and primordial germ cell migration.-10. Human embryonic stem cells in serum-free media: growth and metabolism. I. MOLECULAR GENETICS.-11. Evolutionary dynamics of mutations in hematopoietic stem cells and beyond.-12. Isolated corneal epithelial stem cells derived from limbal biopsies: use of lectin as a marker for identifying transient amplifying cells.-13. Stem cell distribution and mgmt expression in glioblastoma: role of intratumoral hypoxic gradient.- 14. Initiation of human tumourigenesis: upregulation of foxm1 transcription factor. II THERAPY.-15. Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy.-16.Ccell-based regenerative therapies: role of major histocompatibility complex-1 antigen.-17. Mesenchymal stem cells for cellular therapies.-18. Radiation burns and mesenchymal stem cell therapy.-19. Mesenchymal stem cells: role of mechanical strain in promoting apoptosis and differentiation.-20. Human mesenchymal stem cells: melatonin as a potential anti-osteoporosis drug.-21. Applications of human - induced pluripotent stem cell derived hepatocytes.-22. Stem cells and gastric carcinogenesis: from mouse to human.-23. Gain and loss of cancer stem cells: effect on metastatic efficiency and treatment response.-24. Treatment of ischemia/reperfusion injury of the kidney with mesenchymal stromal cells.-25. Mesenchymal stem cells: role for delivering nanoparticles to brain tumors.-26. Human induced pluripotent stem cells: role in patient specific drug discovery.-27. Biomedical applications of induced pluripotent stem cells.-28. Duchenne muscular dystrophy: isolation of cd133-expressing myogenic progenitors from blood and muscle of dmd patients. III TRANSPLANTATION.-29. Human fetal mesenchymal stem cells for prenatal and postnatal transplantation.-30. Protection of mice from stroke using hematopoietic stem cell transplantation.-31. Neonatel hypoxic-ischemic encephalopathy: neural stem/progenitor cell transplantation. IV TISSUE REGENERATION.-32. Mesenchymal stem cell-dependent formation and repair of tendon-done insertions.-33 . Cartilage injuries: role of implantation of human stem/progenitor cells.-34. Bone marrow-derived very small embryonic-like cells: I -cell regeneration in pancreatic tissue.- 35. Engineering stem cell niche: regulation of cellular morphology and function.- V APOPTOSIS.-36. Embryonic stem cells: the role of nitric oxide in regulating cell differentiation, self-renewal, and apoptpsis.- 37. Induction of apoptosis in human keratinocyte stem cells: the role of hydrogen sulfide. Index